Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Chitosan hydrogel as siRNA vector for prolonged gene silencing.

Ma Z, Yang C, Song W, Wang Q, Kjems J, Gao S.

J Nanobiotechnology. 2014 Jun 19;12:23. doi: 10.1186/1477-3155-12-23.

2.
3.

[Chitosan-siRNA complex nanoparticles for gene silencing].

Liu X.

Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2010 Feb;27(1):97-101. Chinese.

PMID:
20337033
4.

The influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencing.

Liu X, Howard KA, Dong M, Andersen MØ, Rahbek UL, Johnsen MG, Hansen OC, Besenbacher F, Kjems J.

Biomaterials. 2007 Feb;28(6):1280-8.

PMID:
17126901
5.

PEG-g-chitosan thermosensitive hydrogel for implant drug delivery: cytotoxicity, in vivo degradation and drug release.

Jiang G, Sun J, Ding F.

J Biomater Sci Polym Ed. 2014;25(3):241-56. doi: 10.1080/09205063.2013.851542.

PMID:
24160458
7.

Chitosan Nanoparticles for SiRNA Delivery In Vitro.

Ragelle H, Vanvarenberg K, Vandermeulen G, Préat V.

Methods Mol Biol. 2016;1364:143-50. doi: 10.1007/978-1-4939-3112-5_12.

PMID:
26472448
8.

Potential application of injectable chitosan hydrogel treated with siRNA in chronic rhinosinusitis therapy.

Cao C, Yan C, Hu Z, Zhou S.

Mol Med Rep. 2015 Nov;12(5):6688-94. doi: 10.3892/mmr.2015.4237.

9.

Chitosan/siRNA functionalized titanium surface via a layer-by-layer approach for in vitro sustained gene silencing and osteogenic promotion.

Song W, Song X, Yang C, Gao S, Klausen LH, Zhang Y, Dong M, Kjems J.

Int J Nanomedicine. 2015 Mar 24;10:2335-46. doi: 10.2147/IJN.S76513.

10.

An inhalable β₂-adrenoceptor ligand-directed guanidinylated chitosan carrier for targeted delivery of siRNA to lung.

Luo Y, Zhai X, Ma C, Sun P, Fu Z, Liu W, Xu J.

J Control Release. 2012 Aug 20;162(1):28-36. doi: 10.1016/j.jconrel.2012.06.005.

PMID:
22698944
11.

Nebulised siRNA encapsulated crosslinked chitosan nanoparticles for pulmonary delivery.

Sharma K, Somavarapu S, Colombani A, Govind N, Taylor KM.

Int J Pharm. 2013 Oct 15;455(1-2):241-7. doi: 10.1016/j.ijpharm.2013.07.024.

PMID:
23876499
12.

Novel biotinylated chitosan-graft-polyethyleneimine copolymer as a targeted non-viral vector for anti-EGF receptor siRNA delivery in cancer cells.

Darvishi MH, Nomani A, Amini M, Shokrgozar MA, Dinarvand R.

Int J Pharm. 2013 Nov 18;456(2):408-16. doi: 10.1016/j.ijpharm.2013.08.069.

PMID:
24012865
13.

A chitosan-dipotassium orthophosphate hydrogel for the delivery of Doxorubicin in the treatment of osteosarcoma.

Ta HT, Dass CR, Larson I, Choong PF, Dunstan DE.

Biomaterials. 2009 Jul;30(21):3605-13. doi: 10.1016/j.biomaterials.2009.03.022.

PMID:
19345993
14.

Chitosan nanoparticles for siRNA delivery: optimizing formulation to increase stability and efficiency.

Ragelle H, Riva R, Vandermeulen G, Naeye B, Pourcelle V, Le Duff CS, D'Haese C, Nysten B, Braeckmans K, De Smedt SC, Jérôme C, Préat V.

J Control Release. 2014 Feb 28;176:54-63. doi: 10.1016/j.jconrel.2013.12.026.

PMID:
24389132
15.
16.

Chitosan as a carrier for targeted delivery of small interfering RNA.

Rudzinski WE, Aminabhavi TM.

Int J Pharm. 2010 Oct 31;399(1-2):1-11. doi: 10.1016/j.ijpharm.2010.08.022. Review.

PMID:
20732398
17.

Ternary polymeric nanoparticles for oral siRNA delivery.

Zhang J, He C, Tang C, Yin C.

Pharm Res. 2013 May;30(5):1228-39. doi: 10.1007/s11095-012-0961-8.

PMID:
23307349
18.

Controlled release of paclitaxel from photocrosslinked chitosan hydrogels and its subsequent effect on subcutaneous tumor growth in mice.

Obara K, Ishihara M, Ozeki Y, Ishizuka T, Hayashi T, Nakamura S, Saito Y, Yura H, Matsui T, Hattori H, Takase B, Ishihara M, Kikuchi M, Maehara T.

J Control Release. 2005 Dec 10;110(1):79-89.

PMID:
16289419
19.

The suppression of lung tumorigenesis by aerosol-delivered folate-chitosan-graft-polyethylenimine/Akt1 shRNA complexes through the Akt signaling pathway.

Jiang HL, Xu CX, Kim YK, Arote R, Jere D, Lim HT, Cho MH, Cho CS.

Biomaterials. 2009 Oct;30(29):5844-52. doi: 10.1016/j.biomaterials.2009.07.017.

PMID:
19640582
20.

Megalin-mediated specific uptake of chitosan/siRNA nanoparticles in mouse kidney proximal tubule epithelial cells enables AQP1 gene silencing.

Gao S, Hein S, Dagnæs-Hansen F, Weyer K, Yang C, Nielsen R, Christensen EI, Fenton RA, Kjems J.

Theranostics. 2014 Aug 13;4(10):1039-51. doi: 10.7150/thno.7866.

Items per page

Supplemental Content

Support Center